Chris Wagner

Chris Wagner

Verkställande Direktör på
Immunoflex Therapeutics, Inc.
57 år
Health Technology
Consumer Services
Industrial Services

Profil

Chris Wagner was the founder of Canexia Health, Inc. (Canada), founded in 2012, where the title held was Chief Executive Officer.
Mr. Wagner is also the founder of Aspreva Pharmaceuticals Corp.,Immunoflex Therapeutics, Inc...
Mr. Wagner currently holds the position of Director at Contextual Health since 2019.
Mr. Wagner also serves as Area Manager-New Mexico at Meridian Engineering Co. Former positions include President & Chief Executive Officer at Sirius Genomics, Inc., Director at Emerald Health Therapeutics, Inc. from 2018 to 2019, Independent Director at Filament Health Corp.
from 2021 to 2024, and Principal at Eli Lilly & Co. Education includes undergraduate studies at the University of British Columbia.

Aktiva positioner av Chris Wagner

FöretagPositionStart
Direktör/Styrelseledamot 2019-05-01
Företagsledare/Principal -
Immunoflex Therapeutics, Inc.
Verkställande Direktör -

Tidigare kända positioner av Chris Wagner

FöretagPositionSlut
FILAMENT HEALTH CORP. Direktör/Styrelseledamot 2024-04-01
EMERALD HEALTH THERAPEUTICS Verkställande Direktör 2018-11-28
Verkställande Direktör -
Grundare -
ELI LILLY AND COMPANY Företagsledare/Principal -
Se detaljerna i Chris Wagners erfarenhet

Chris Wagners utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

8

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Process Industries

Health Technology

Health Technology

Immunoflex Therapeutics, Inc.

Health Services

  1. Börsen
  2. Insiders
  3. Chris Wagner